SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-17-092797
Filing Date
2017-03-23
Accepted
2017-03-23 07:37:04
Documents
3
Period of Report
2017-03-21
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d319463d8k.htm 8-K 49964
2 EX-3.1 d319463dex31.htm EX-3.1 35408
3 EX-4.1 d319463dex41.htm EX-4.1 283179
  Complete submission text file 0001193125-17-092797.txt   370221
Mailing Address 225 SOUTH LAKE AVENUE SUITE 1050 PASADENA CA 91101
Business Address 225 SOUTH LAKE AVENUE SUITE 1050 PASADENA CA 91101 626-304-3400
ARROWHEAD PHARMACEUTICALS, INC. (Filer) CIK: 0000879407 (see all company filings)

IRS No.: 460408024 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 000-21898 | Film No.: 17708150
SIC: 2834 Pharmaceutical Preparations